Whole-genome amplified DNA from stored dried blood spots is reliable in high resolution melting curve and sequencing analysis

[1]  K. Aoki.  Newborn screening in Japan. , 2022, The Southeast Asian journal of tropical medicine and public health.

[2]  Erin Rothwell,et al.  Newborn Screening , 2011, Annual Review of Nursing Research.

[3]  T. Jespersen,et al.  Inherited Cardiac Diseases Caused by Mutations in the Nav1.5 Sodium Channel , 2010, Journal of cardiovascular electrophysiology.

[4]  T. Ørntoft,et al.  Genome-wide scans using archived neonatal dried blood spot samples , 2009, BMC Genomics.

[5]  D. Hougaard,et al.  Genotyping whole‐genome‐amplified DNA from 3‐ to 25‐year‐old neonatal dried blood spot samples with reference to fresh genomic DNA , 2009, Electrophoresis.

[6]  Li Li,et al.  Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation , 2009, Journal of Human Genetics.

[7]  E. Silverman,et al.  High-resolution melting curve analysis of genomic and whole-genome amplified DNA. , 2008, Clinical chemistry.

[8]  P. Lambiase,et al.  Genetic aspects and investigation of sudden death in young people. , 2008, Clinical medicine.

[9]  P. Vargas,et al.  Newborn screening: A national public health programme in Brazil , 2007, Journal of Inherited Metabolic Disease.

[10]  J. Carlson,et al.  Assessing quality and functionality of DNA from fresh and archival dried blood spots and recommendations for quality control guidelines. , 2007, Clinical chemistry.

[11]  B. Therrell,et al.  Newborn screening in North America , 2007, Journal of Inherited Metabolic Disease.

[12]  D. Hougaard,et al.  Storage policies and use of the Danish Newborn Screening Biobank , 2007, Journal of Inherited Metabolic Disease.

[13]  A. Syvänen,et al.  Multiple displacement amplification to create a long‐lasting source of DNA for genetic studies , 2006, Human mutation.

[14]  M. Lindegren,et al.  Storage and use of residual dried blood spots from state newborn screening programs. , 2006, The Journal of pediatrics.

[15]  Beverley Balkau,et al.  Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population , 2005, European Journal of Human Genetics.

[16]  N. Longo,et al.  Validation of dye‐binding/high‐resolution thermal denaturation for the identification of mutations in the SLC22A5 gene , 2005, Human mutation.

[17]  D. Roden,et al.  Polymorphism Screening in the Cardiac K+ Channel Gene KCNA5 , 2005, Clinical pharmacology and therapeutics.

[18]  M. Viitasalo,et al.  Four potassium channel mutations account for 73% of the genetic spectrum underlying long‐QT syndrome (LQTS) and provide evidence for a strong founder effect in Finland , 2004, Annals of medicine.

[19]  B. No̸rgaard-Pedersen,et al.  Biological specimen banks in neonatal screening , 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[20]  Michael R. Glass,et al.  Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: statement of the Council of Regional Networks for Genetic Services. , 1996, Biochemical and molecular medicine.

[21]  Yoosoo Chang,et al.  Whole Genome Amplification and Genetic Analysis after Extraction of Proteins from Dried Blood Spots , 2007 .

[22]  Yi Wang,et al.  BMC Medical Genetics , 2007 .

[23]  K. Quek,et al.  Toxoplasmosis in HIV/AIDS patients in Malaysia. , 2003, The Southeast Asian journal of tropical medicine and public health.